microbio weiss ppt

0.0(0)
Studied by 1 person
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/85

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 3:04 PM on 3/9/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

86 Terms

1
New cards

growth spurts

driven by technologic advances: invention of tools, agriculture, industry

2
New cards

plateaus

set by birth/death rates – limiting factors: disease, famine, war, birth control

3
New cards

how is the agricultural revolution associated with disease?

crowding - enhanced disease transmission (respiratory), human/animal manure as fertilizer (water/foodborne disease), poor nutrition from primarily grain crops

4
New cards

origin of influenza a

ducks, pigs, wild birds

5
New cards

origin of measles

cattle

6
New cards

origin of smallpox

camels

7
New cards

origin of tuberculosis

ruminants

8
New cards

origin of mumps

mammals, possibly pigs

9
New cards

origin of rotavirus a

domestic herbivores

10
New cards

origin of diphtheria

domestic herbivores

11
New cards

origin of pertussis

mammals

12
New cards

origin of plague and typhus

rodents

13
New cards

origin of cholera

aquatic organisms

14
New cards

origin of hepatitis b

apes

15
New cards

origin of aids

chimpanzees

16
New cards

origin of yellow fever

african primates

17
New cards

origin of dengue fever

old world primates

18
New cards

emerging infectious diseases

diseases that have increased recently or could increase in the near future

19
New cards

zoonotic

transmission to humans from animal reservoir

20
New cards

why is zoonotic transmission from bats high?

ability to fly, body temperature fluctuations, roosting habits, migration, hibernation

21
New cards

human monoclonal antibodies

isolate antibody-producing cells from convalescent individuals, clone and sequence the antibody genes, prepare synthetic human antibodies

22
New cards

cause of death categories

communicable (infectious and parasitic diseases, maternal, perinatal, and nutritional conditions), noncommunicable (chronic), injuries

23
New cards

years of potential life lost (ypll)

assesses "premature“, "preventable“, and "unnecessary" mortality

24
New cards

crude mortality

treats deaths at all ages equally

25
New cards

major causes of death years 1-9

unintentional injuries, cancer, congenital malformation

26
New cards

major causes of death years 10-24

injuries, suicide, homicide, cancer

27
New cards

major causes of death years 65+

heart disease, cancer, chronic lower respiratory disease

28
New cards

what receives low funding

gun violence and falls

29
New cards

what receives high funding

HIV

30
New cards

disability adjusted life years (daly)

number of productive years lost due to ill-health, disability, or early death

31
New cards

disease

a change from general good health, involving disruption of normal structure or functioning of body

32
New cards

disease causes

inadequate nutrition, genetic abnormalities, structural or functional disorders, trauma

33
New cards

infectious agents

prions, viruses, bacteria, fungi (protozoa)

34
New cards

prions

single protein – too small to represent here

35
New cards

viruses

average about 100 nanometers; have few proteins; must commandeer the machinery of the

cells they invade to reproduce

36
New cards

bacteria

sizes vary, but are at least ten times bigger than viruses; single cell organisms, and can reproduce independently

37
New cards

single-celled parasites

at least ten times larger than bacteria

38
New cards

multicellular parasites

so large they can often be seen with the naked eye; tapeworms can be 20 feet long

39
New cards

eubacteria

bacteria of medical importance

40
New cards

archaebacteria

collection of evolutional distinct organisms; primarily found in extreme terrestrial and aquatic environments

41
New cards

where do antibiotics work?

cell wall and cytoplasm

42
New cards

where do antibodies work?

cell-surface

43
New cards

PAMPS - pathogen-associated molecular patterns

conserved structures on microorganisms, genetically encoded to be recognized by the innate immune system, jump-start the immune response, and can cause symptoms of disease in the absence of living bacteria, including the cell wall structures of bacteria

44
New cards

cell wall (peptidoglycan)

protects from environmental stresses, provides strength, maintains bacterial shape, limits penetration of molecules

45
New cards

medical importance of cell wall

protects from some host defenses, role in adherence to host cells

46
New cards

selective toxicity

unique to bacteria, target for many antibiotics

47
New cards

capsule functions

protection from harsh environment, permeability barrier, surface attachment - including host tissues, mutans attaches to teeth and causes tooth decay), capsules are antigenic – can induce protective antibodies that promote engulfment by phagocytes

48
New cards

capsule pathogenicity (survival in host)

encapsulated = virulent; no capsule = avirulent

49
New cards

what does the capsule protect bacteria from

phagocytosis

50
New cards

flagella

rope-like filaments of coiled flagellin

51
New cards

role of motility in pathogenesis

mediates tissue invasion, traverse cellular/extracellular barriers

52
New cards

chemotaxis

swim through intestinal mucus barrier, access intestinal cells

53
New cards

pili

attachment of environmental surfaces, bacterial sex (conjugation), host cells; transformation (uptake of DNA)

54
New cards

sporulation

bacteria form endospores

55
New cards

endospores

highly resistant, dormant structures—to survive harsh environmental conditions

56
New cards

what are spores resistant to killing by

heat (2+ hours boiling), drying, freezing, pH extremes, deterious chemicals, antibiotics, radiation

57
New cards

sterilization procedures

bleach, autoclaving (exposure to high temperature and pressure)

58
New cards

toxicity steps

1. b-component binds to receptors on the host target cell

2. b-component promotes entry and cellular trafficking of toxic a-component

3. a-component causes a specific alteration in the target cell that leads to the dire consequences

59
New cards

cytolytic toxins

cause cell lysis

60
New cards

cytotoxic toxins

cause metabolic alterations

61
New cards

most deathly agents

tetanus and botulinum toxin

62
New cards

diphtheria toxin

inactivates ribosomes, protein synthesis stops, and cell dies

63
New cards

diphtheria

upper respiratory tract infection, transmitted by droplets, leads to airway obstruction, toxic myocarditis and heart failure, and nerve paralysis

64
New cards

cholera toxin

leads to watery diarrhea

65
New cards

tetanus and botulinum toxins

no vesicle fusion, blocks release of neurotransmitters (botulinum blocks release of acetylcholine)

66
New cards

c. tetani

produces tetanus toxin; characterized by uncontrollable muscle contractions; spastic paralysis

67
New cards

c. botulinum

produces botulinum toxin, characterized by flaccid paralysis

68
New cards

virulence

degree of pathogenicity of a microorganism, or how effectively it can cause disease in a host

69
New cards

vaccines

contain agent that represents disease-causing organism that’s often made from weakened/killed forms of microbe that stimulates immune system to recognize it as a threat and destroy it if it encounters it in the future

70
New cards

active immunization

produced by pathogen

naturally acquired = recovery from infection

artificially acquired = vaccination

71
New cards

passive immunization

produced by antibodies or cell from an immune individual

naturally acquired - maternal transfer of immunoglobulin via milk

artificially acquired - immune globulin

72
New cards

toxoids

chemically or genetically inactivated toxins with immunogenicity retained

73
New cards

attenuated pathogens

live agents that induce a protective immune response without causing disease

74
New cards

adjuvants

substances that enhance immune response, ex. alum, Freund’s adjuvant

75
New cards

humoral immunity

antibodies are produced to clear or inactivate toxins or pathogens circulating outside the

cells in our body; activated by extracellular antigens; effective against many bacteria and toxins, some circulating viruses

76
New cards

cellular immunity

t-cells are produced that recognize and kill infected cells or induce inflammatory responses; immunity induced by antigens produced inside cells; effective against viral infection

77
New cards

killed vaccine pros + cons

pros: low-tech, easy to prepare, cheap

cons: toxicity, short-term immunity

78
New cards

attenuated vaccine pros + cons

pros: sustained stimulus, right immunity

cons: reversion to virulence, harmful to immunocompromised

79
New cards

subunit vaccine pros + cons

pros: low toxicity, no reversion

cons: poorly immunogenic, may need adjuvant, expensive

80
New cards

killed (inactivated) vaccine examples

non-viable pathogens
bacterial: pertussis, cholera, plague, typhoid, anthrax

viral: polio, influenza, hepatitis A, rabies, encephalitis virus

81
New cards

subunit vaccine examples

antigenic components

toxoids: inactivated toxins. ex. diphtheria, tetanus

capsules: often conjugated with proteins to improve immunogenicity, ex. H. influenzae (Type B), N. meningitidis, streptococcus pneumoniae (23 capsule types)

bacterial: pertussis

viral: hepatitis B surface antigen, human papillomaviruses

82
New cards

live-attenuated vaccine examples

bacterial: BCG for tuberculosis, tularemia, typhoid fever

viral: polio, measles, mumps, rubella, chicken pox, adenovirus, yellow fever, smallpox, rotavirus, influenza

83
New cards

RNA vaccines

covid-19

84
New cards

herd immunity

transmission is limited, unvaccinated are protected

85
New cards

efficacy

calculated by comparing the number of cases of disease in the vaccinated population vs. a control group in an exposed population

86
New cards

VAERS - vaccine adverse event reporting system

voluntary reporting system for reporting adverse events after vaccination